Corticobasal Degeneration Clinical Trials

10 recruiting

Corticobasal Degeneration Trials at a Glance

11 actively recruiting trials for corticobasal degeneration are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Boston, Baltimore, and Rochester. Lead sponsors running corticobasal degeneration studies include Beijing Tiantan Hospital, Beth Israel Deaconess Medical Center, and Bastyr University.

Browse corticobasal degeneration trials by phase

Treatments under study

About Corticobasal Degeneration Clinical Trials

Looking for clinical trials for Corticobasal Degeneration? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Corticobasal Degeneration trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Corticobasal Degeneration clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Not Applicable

The Swedish BioFINDER 2 Study

DementiaMultiple System AtrophyAlzheimer Disease+10 more
Skane University Hospital2,950 enrolled2 locationsNCT03174938
Recruiting
Not Applicable

Scrambler Therapy for Corticobasal Syndrome-Associated Pain

Corticobasal SyndromeCorticobasal DegenerationPain, Neuropathic
Johns Hopkins University25 enrolled1 locationNCT05653778
Recruiting

The CurePSP Genetics Program

PSPPSP - Progressive Supranuclear PalsyCorticobasal Syndrome+4 more
Massachusetts General Hospital1,000 enrolled1 locationNCT06647641
Recruiting

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

Amyotrophic Lateral SclerosisCorticobasal Degeneration (CBD)Progressive Supranuclear Palsy (PSP)+11 more
Mayo Clinic2,100 enrolled27 locationsNCT04363684
Recruiting

Imaging Studies in Corticobasal Syndrome

Corticobasal SyndromeCorticobasal Syndrome(CBS)Corticobasal Degeneration+2 more
Jennifer Whitwell80 enrolled1 locationNCT07000851
Recruiting

Gait Analysis in Neurological Disease

Multiple System AtrophyHuntington DiseaseCorticobasal Degeneration+5 more
Beth Israel Deaconess Medical Center120 enrolled1 locationNCT02994719
Recruiting

AI-Enhanced Optimization of Acute Levodopa Challenge Test

Corticobasal Degeneration (CBD)Parkinson Disease (PD)Vascular Parkinsonism+2 more
Beijing Tiantan Hospital2,000 enrolled1 locationNCT06949865
Recruiting

NYSCF Scientific Discovery Biobank

Ovarian CancerCervical CancerDiabetes Mellitus+26 more
New York Stem Cell Foundation Research Institute10,000 enrolled1 locationNCT06203106
Recruiting
Not Applicable

The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related Disorders

Multiple System AtrophyCorticobasal DegenerationDystonia+5 more
Queen Mary University of London70 enrolled1 locationNCT06174948
Recruiting

Neurodegenerative Diseases Progression Markers (MARKERS-NDD)

Cognitive ImpairmentDementiaMultiple System Atrophy+15 more
Casa di Cura San Raffaele Cassino600 enrolled1 locationNCT06596746
Recruiting

Modifiable Variables in Parkinsonism (MVP)

Corticobasal DegenerationDementia With Lewy BodiesProgressive Supranuclear Palsy+6 more
Bastyr University2,000 enrolled1 locationNCT02194816